Frankfurt, Germany - Isochem Kautschuk GmbH has responded to allegations of patent infringement made by Albemarle Corp., by saying that it believes Albemarle's views are unjustified.Albemarle recently filed suit against Isochem at a court in Düsseldorf, Germany, alleging that Isochem had infringed its patent covering a specific production process of the substance DPE (decabromodiphenyl ethane) by importing it from a foreign supplier."Isochem Kautschuk GmbH is a strong supporter of intellectual property rights. Therefore, it is part of our standard vetting process for suppliers to query them extensively about the processes they employ, to make sure that no patent violation occurs," said the company in a 24 Aug statement."We were able to make sure that our supplier employs production processes that do not violate Albemarle's patent," added the company.Isochem says that it is unsure as to why Albemarle did not contact it before filing suit, as "even a cursory exchange of crucial information regarding the processes used could have saved both companies a lot of time and effort."The company believes that this litigation is part of Albemarle's strategy to gain market share. "There are numerous suppliers and importers of DPE - To our knowledge, none of these companies have been sued," said Isochem."We can only speculate that this suit is part of a new strategy that seeks to increase Albemarle's market share through litigation, as opposed to actually competing based on quality and price." It added.Isochem said that it remains committed to international intellectual property rights and will prove in court that Albemarle's patents have not been violated. (ss)"